U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM

Kidney International

Volumn 48, Issue 6, 1995, Pages 1907-1911

  Dudley, Christopher R K ^b   Keavney, Bernard ^b   Stratton, Irene M ^b   Turner, Robert C ^b   Ratcliffe, Peter J ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINOPATHY; UNITED KINGDOM;

EID: 0028792259     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.490     Document Type: Article

References (25)

1. MOGENSEN CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
2. MOGENSEN CE, DAMSGAARD EM, FROLAND A, NIELSEN S, DE FINE OLIVARIUS N, SCHMITZ A: Microalbuminuria in non-insulin-dependent diabetes. Clin Nephrol 38(Suppl 1):S28-S39, 1992
3. PETTITT DJ, SAAD MF, BENNETT PH, NELSON RG, KNOWLER WC: Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
4. GRENFELL A, BEWICK M, PARSONS V, SNOWDEN S, TAUBE D, WATKINS PJ: Non-insulin-dependcnt diabetes and renal replacement therapy. Diabet Med 5:172-176, 1987
5. BALLERMAN BJ, ZEIDEL ML, GUNNING ME, BRENNER BM: Vasoactive peptides and the kidney, in The Kidney, edited by BRENNER BM, RECTOR FC, Philadelphia, Saunders, 1991, pp 510-583
6. RAVID M, SAVIN H, JUTRIN I, KATZ B, LISHNER M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118:577-581, 1993
7. VIBERTI G, MOGENSEN CE, GROOP LC, PAULS JF: Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and miroalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 271:275-279, 1994
8. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
9. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence from combined segregation and linkage analysis that a variant of the angiotensin 1-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
10. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU J-P, ARVEILER D, LUC G, BARD J-M, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-44, 1992
11. KEAVNEY B, DUDLEY C, STRATTON I, HOLMAN R, MATTHEWS D, RATCLIFFE P, TURNER R: U.K. Prospective Diabetes Study (UKPDS) XIV: Association of ACE insertion/deletion polymorphism with myocardial infarction in non-insulin dependent diabetes (NIDDM). Diabetologia 38:948-952, 1995
12. MARRE M, BERNADET P, GALLOIS Y, SAVAGNER F, GUYENE T-T, HALLAB M, CAMBIEN F, PASSA P, ALHENC-GELAS F: Relationship between angiotensin 1 converting enzyme gene polymorphism, plasma levels, and diabetic complications. Diabetes 43:384-388, 1994
13. FOGARTY DG, HUGHES AE, NEVIN NC, DOHERTY CC, MAXWELL AP: Functional genetic markers of the renin-angiotensin system and the risk of diabetic nephropathy in insulin-dependent diabetes melitus. (abstract) J Am Soc Nephrol 5:376, 1994
14. SCHMIDT S, SCHONE N, GIESSEL R, BERGIS K, RITZ E: Association of the ACE gene polymorphism and diabetic nephropathy. (abstract) J Am Soc Nephrol 5:383, 1994
15. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV YV, LIFTON RP, WILLIAMS CS, CHARRU A, HUNT SC, HOPKINS PN, WILLIAMS RR, LALOUEL J-M, CORVOL P: Molecular basis of human hypertension: Role of angiotensinogen. Cell 71:169-180, 1992
16. WARD K, HATA A, JEUNEMAITRE X, HELIN C, NELSON L, NAMIKAWA C, FARRINGTON PF, OGASAWARA M, SUZUMORI K, TOMODA S, BERREBI S, SASAKI M, CORVOL P, LIFTON RP, LALOUEL J-M: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 4:59-61, 1993
17. UK PROSPECTIVE DIABETES STUDY GROUP: UK Prospective Diabetes Study (UKPDS) VIII. Study design, progress and performance. Diabetologia 34:877-890, 1991
18. KEARNEY EM, MOUNT JN, WATTS GF, SLAVIN BM, KIND PRN: Simple immunoturbidimetric method for determining urinary albumin at low concentrations using a Cobas-Bio centrifugal analyser. J Clin Pathol 40:465-468, 1987
19. THOMPSON SG, BARLOW RD, WALD NJ, VAN VUNAKIS H: How should urinary cotinine concentrations be adjusted for urinary creatinine concentration? Clin Chim Acta 187:289-296, 1990
20. UK PROSPECTIVE DIABETES STUDY GROUP: UK Prospective Diabetes Study (UKPDS) XI: Biochemical risk factors in Type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabetic Med 11:534-544, 1994
21. RIGAT B, HUBERT C, CORVOL P, SOUBRIER F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase). Nucl Acid Res 20:1433, 1992
22. SHANMUGAM V, SELL KW, SAHA BK: Mistyping ACE heterozygotes. PCR Meth Appl 3:120-121, 1993
23. RUSS AP, MAERZ W, RUZICKA V, STEIN U, GROSS W: Rapid detection of the hypertension-associated Met235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 2:609-610, 1993
24. CAULFIELD M, LAVENDER P, FARRALL M, MUNROE P, LAWSON M, TURNER P, CLARK AJL: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633, 1994
25. PEI Y, SCHOLEY J, PHAI K, MILLER JA: Relationship between angiotensin I converting enzyme (ACE) gene polymorphism and renal hemodynamic dysfunction in insulin dependent diabetes mellitus. (abstract) J Am Soc Nephrol 5:382, 1994